🇺🇸 FDA
Patent

US 7338758

Compositions and methods for the identification, assessment, prevention and therapy of human cancers

granted A61PA61P35/00

Quick answer

US patent 7338758 (Compositions and methods for the identification, assessment, prevention and therapy of human cancers) held by The Board of Regents of the University of Texas System expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P35/00